Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

Composite Hydrogels with Embedded Electrospun Fibers as Drug Delivery Systems

Fuioaga PC., Rata DM., Riaz T., Rivero G., Abraham GA., Atanase LI.

Narrative Review on Face & Skin, published in Gels (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Gels (2025)
Reported sample size
—
Source database
Europe PMC
PMID
41149429
PMCID
PMC12564823
DOI
10.3390/gels11100826
Citations
1

Abstract (original English)

Hydrogel/electrospun polymer nanofiber composites (HENC) integrate the advantages of both components. Hydrogels provide high water content, biocompatibility, and tunable drug release, while electrospun nanofibers offer a high surface area, loading capacity, customizable morphology, and opportunities for functionalization. Nanofibers can also be incorporated into hydrogels as 3D-printable inks. Together, these features create biomimetic composites that modulate drug release and mimic native tissues. This article reviews electrospinning fundamentals, limitations, preparation methods for HENC, and their applications in drug delivery, as well as future perspectives for developing advanced functional materials with improved therapeutic efficacy, controlled release kinetics, and broad biomedical adaptability.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research